CatX enhances migratory and invasive properties of tumor cells by interacting with integrin receptors and profilin‐1 [160, 161, 162] and promotes tumor progression by compensating CatB proteolytic activity [163, 164], bypassing senescence [165], and inducing EMT [142, 166]. The gene discussed is TYRP1; the disease is neoplasm.